Reliance Infrastructure, Afcons and Narayana Hrudayalaya will be among 202 companies to post earnings reports for the January ...

With the Mumbai-based ... its biggest market for pharmaceutical products manufactured in India, including generic or off-patent drugs and pricier branded products. Indian pharma companies will ...

Amid a backdrop of easing trade tensions between the U.S. and China, global markets have experienced a notable rally, with ...

As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have ...

London-based FTSE Russell will remove Indian firm STL Networks Ltd. from the FTSE Global Small Cap Index for failing to list ...

Equity markets open positively, Nifty and Sensex rise, IT and consumer stocks lead gains, global cues favorable.

Bristol-Myers Squibb $74 billion takeover of Celgene saw it shoot up the list of top 20 pharma companies by market cap into the top 10, according to a new analysis by GlobalData. BMS had the ...

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech ETFs, ...

Indian equity markets experienced a sharp decline on Tuesday, with the Sensex and Nifty50 falling significantly due to global ...

Capricor Therapeutics is seeking FDA approval for CAP-1002, targeting heart function in Duchenne Muscular Dystrophy patients.

Royalty Pharma plc (Nasdaq: RPRX) today announced that it has successfully closed the acquisition of its external manager, RP Management, LLC (“RP Management”). The acquisition received overwhelming ...